Advanced Search

Technical Analysis for NMDBF - NeonMind Biosciences Inc

Grade Last Price % Change Price Change
D 0.131 -7.75% -0.0110
NMDBF closed down 7.75 percent on Friday, June 18, 2021, on 1.5 times normal volume.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Up
Historical NMDBF trend table...
Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
Fell Below 50 DMA Bearish -7.75%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -7.75%
Volume Surge Other -7.75%
Calm After Storm Range Contraction -7.75%
Inside Day Range Contraction -7.75%
Above Upper BB Strength -7.75%
Upper Bollinger Band Touch Strength -7.75%
20 DMA Support Bullish -10.94%
Pocket Pivot Bullish Swing Setup -10.94%
Older End-of-Day Signals for NMDBF ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible Inside Day 3 days ago
Down 5% 3 days ago
Down 3% 3 days ago
Down 2% 3 days ago
Down 1% 3 days ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators Basic chart:

Profile

NeonMind Biosciences Inc. engages in the discovery, development, and commercialization of medicinal and psychedelic mushrooms for mental illnesses. It is developing psilocybin based products comprising mushroom-infused beverages and other mushroom-infused products to treat weight loss and management, depression, cardiovascular, obesity, diabetes, and heart diseases. The company was formerly known as Flourish Mushroom Labs Inc. and changed its name to NeonMind Biosciences Inc. in April 2020. NeonMind Biosciences Inc. was incorporated in 2019 and is headquartered in Vancouver, Canada. NeonMind Biosciences Inc. is a subsidiary of The Yield Growth Corp.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Entheogens Diabetes Obesity Depression Heart Diseases Psychoactive Fungi Shrooms

Is NMDBF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
May 10 NeonMind to Present at the Benzinga Global Small Cap Conference
May 6 BTV Explores Investment Options in Life Sciences
Mar 11 NeonMind Engages Certara to Advance its Synthetic Psilocybin Drug Candidates for Obesity
Feb 24 NeonMind Purchases GMP Grade Synthetic Psilocybin from Psygen Labs for Phase 2 Human Clinical Trial
See more NMDBF news...

Indicators

Indicator Value
52 Week High 0.4
52 Week Low 0.115
Average Volume 131,980
200-Day Moving Average 0.0000
50-Day Moving Average 0.1452
20-Day Moving Average 0.1268
10-Day Moving Average 0.1284
Average True Range 0.0152
ADX 23.64
+DI 25.2336
-DI 10.6075
Chandelier Exit (Long, 3 ATRs) 0.1155
Chandelier Exit (Short, 3 ATRs) 0.1606
Upper Bollinger Bands 0.1409
Lower Bollinger Band 0.1127
Percent B (%b) 0.65
BandWidth 22.2397
MACD Line -0.0029
MACD Signal Line -0.0062
MACD Histogram 0.0033
Fundamentals Value
Market Cap 15.73 Million
Num Shares 120 Million
EPS
Price-to-Sales 41.83
Price-to-Book 7.01
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.1477
Resistance 3 (R3) 0.1488 0.1444 0.1449
Resistance 2 (R2) 0.1444 0.1402 0.1438 0.1439
Resistance 1 (R1) 0.1377 0.1375 0.1355 0.1366 0.1430
Pivot Point 0.1333 0.1333 0.1322 0.1327 0.1333
Support 1 (S1) 0.1266 0.1291 0.1244 0.1255 0.1190
Support 2 (S2) 0.1222 0.1264 0.1216 0.1181
Support 3 (S3) 0.1155 0.1222 0.1171
Support 4 (S4) 0.1144